RoseLabs

Ahmedabad, India Founded: 1992 • Age: 34 yrs Listed
Generics manufacturer specializing in parenterals

About RoseLabs

RoseLabs is a Healthcare company based in Ahmedabad (India) founded in 1992 by Pawankumar Agrawal. It operates as a generics manufacturer specializing in parenterals. It operates on a Traditional Pharmaceuticals model. The company has 1 employees. RoseLabs offers products and services including RoseLabs Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified. Its legal entity in India is ROSELABS LIMITED (L51909GJ1995PLC024905).

Company details

RoseLabs, established in 1992, excels in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Generics manufacturer specializing in parenterals. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Ahmedabad, India
  • Employees 1
  • Founders Pawankumar Agrawal
  • Stage Public
  • Sectors
    Healthcare
  • Website roselabsindia.com
  • Legal Name Roselabs Limited
  • Date of Incorporation 07 Mar, 1995
  • Jurisdiction Ahmedabad, Gujarat, India
Key Metrics
  • Net Loss
    -₹1.5 Lakh

    FY 2022 · -533395% margin

  • EBITDA
    -₹1.5 Lakh

    FY 2022 · -532072% margin

  • Employee Count
    1

Products & Services of RoseLabs

RoseLabs offers a comprehensive portfolio of products and services, including RoseLabs Platform.

RoseLabs Platform
Healthcare

Generics manufacturer specializing in parenterals

Board of directors of Roselabs Limited (RoseLabs)

Roselabs Limited is the primary company behind RoseLabs. The board of Roselabs Limited currently have 4 directors; the longest-serving is Pawankumar Trilokchand Agrawal, appointed in 1995. 13 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pawankumar Trilokchand Agrawal
DIN 00015921
Managing Director03 Apr 199531 yrs 6 moRoselabs Limited
Zameer Pawankumar Agrawal
DIN 01409425
Whole-time director20 Mar 200917 yrs 7 moRoselabs Limited
Rahul Rajkumar Agrawal
DIN 05242410
Director25 Feb 201511 yrs 7 moRoselabs Limited
Jayshree Gaurang Patel
DIN 05165455
Director25 Feb 201511 yrs 7 moRoselabs Limited

People of RoseLabs

1 people are tracked at RoseLabs (1 in leadership); the tracked headcount is 1.

NameRoleGroup
Founder & MDLeadership
Premium access

Complete people profiles for RoseLabs

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of RoseLabs

Figures of Roselabs Limited, the primary company behind RoseLabs, for FY 2022. Net loss was -₹1.5 Lakh (-533395% margin). EBITDA was -₹1.5 Lakh (-532072% margin). Revenue has grown at a compounded annual rate of -99% over three years.

  • -₹1.5 LakhNet loss · -533395% margin
  • -₹1.5 LakhEBITDA · -532072% margin
  • ₹10.00 CrPaid-up capital
  • 1Employees (provident fund records)
  • -99%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Roselabs Limited are on its company page.

Premium access

Detailed financial statements for RoseLabs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as RoseLabs (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about RoseLabs

RoseLabs was founded in 1992.

RoseLabs is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

RoseLabs has 1 employees.

Annual revenue of RoseLabs is $0.35 as on Mar 31, 2022.

RoseLabs, established in 1992, excels in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Generics manufacturer specializing in parenterals. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

RoseLabs offers RoseLabs Platform.

RoseLabs operates through Roselabs Limited.

The legal entities of RoseLabs currently have 4 directors, including Pawankumar Trilokchand Agrawal, Zameer Pawankumar Agrawal, Rahul Rajkumar Agrawal and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available